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Aim To explore the mechanism underlying the protective 
effect of adipose-derived mesenchymal stem cells (ADM-
SCs) against ischemic stroke by focusing on miR-21-3p/
MAT2B axis.
Methods Ischemic brain injury was induced in 126 rats 
by middle cerebral artery occlusion (MCAO). The effect of 
ADMSC administration on blood-brain barrier (BBB) condi-
tion, apoptosis, inflammation, and the activity of miR-21-
3p/MAT2B axis was assessed. The role of miR-21-3p inhibi-
tion in the function of ADMSCs was further validated in in 
vitro neural cells.
Results ADMSCs administration improved BBB condition, 
inhibited apoptosis, and suppressed inflammation. It also 
reduced the abnormally high level of miR-21-3p in MCAO 
rats. Dual luciferase assays showed that miR-21-3p directly 
inhibited the MAT2B expression in neural cells, and miR-21
-3p inhibition by inhibitor or ADMSC-derived exosomes in 
neurons attenuated hypoxia/reoxygenation-induced im-
pairments similarly to that of ADMSCs in vivo.
Conclusion This study confirmed the protective effect 
of ADMSCs against ischemic brain injury exerted by sup-
pressing miR-21-3p level and up-regulating MAT2B level.
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Cerebral damage due to ischemic stroke (IS) ranks third 
among mortality-related factors in developed countries 
and substantially contributes to disability rates worldwide 
(1,2). IS kills numerous neurons in the central neuron sys-
tem, and the affected tissue rarely functionally recovers 
(3). The most effective treatment strategy for IS is throm-
bolytics administration. However, the effectiveness of this 
strategy is limited by the narrow time window for its appli-
cation and hemorrhage complications (4,5), stressing the 
need for novel effective approaches with few side effects.
Sequencing techniques enabled the discovery of intrinsic 
factors that regulate neuron survival during IS (6,7). One 
of the potential treatment targets are microRNAs (miRs), 
whose expression and function are influenced by IS (8). 
In an animal model, ischemic injuries affected the ex-
pressions of 114 miRs (9). Also, miR-21 and miR-29b lev-
els responded to oxygen-glucose deprivation in cultured 
neurons and astrocytes (10). Moreover, miR-21-3p level 
suppression by human umbilical vein endothelial cell-de-
rived exosomes attenuated hypoxia/reoxygenation (H/R)-
induced apoptosis in neural cells (11), further confirming 
miR-21 involvement in the progression of IS injuries. IS in-
juries induce the release of cytokines, chemokines, and 
adhesion molecules, which influences the permeability 
of the blood-brain barrier (BBB) (12,13), promoting the 
traffic of leukocytes into brain tissues and exacerbating 
ischemic injuries (12). The increased miR-21-3p level ag-
gravates BBB damage by promoting cellular apoptosis 
and inflammation by modulating MAT2B function (14). 
Therefore, miR-21-3p inhibition by a specific agent might 
be a novel strategy to improve BBB condition in a multi-
pronged IS attack.
Cytotherapy is a promising option for the treatment of IS-
related disorders, with experimentally and clinically proved 
efficacy (15-19). Stem cell-based therapies that modulate 
miRs expression showed considerable feasibility and safety 
(15). For example, bone marrow mesenchymal stem cells 
(BMSCs) have shown promise in the treatment of IS injuries 
(20,21). However, their application is limited due to the inva-
sive methods needed to obtain these cells. Compared with 
BMSCs, adipose-derived mesenchymal stem cells (ADM-
SCs) are an abundant stem cell type easy to obtain with-
out ethical issues (22). Chi et al (23) confirmed that ADMSCs 
alleviated inflammatory response associated with IS and 
improved BBB condition by suppressing endoplasmic re-
ticulum stress. Moreover, the alleviating effect of ADMSCs 
on inflammatory response in a liver injury model was re-
ported to be stronger than that of BMSCs (22). Thus, 
understanding the mechanism behind the anti-IS effect of 
ADMSCs can facilitate the clinical application of these cells. 
The aim of the study was to assess the effect of ADMSCs 
administration on the inflammatory response, BBB perme-
ability, and the activity of miR-21-3p/MAT2B axis.
MeThodS
Adipose-derived mesenchymal stem cells (AdMSCs) 
identification
ADMSCs were provided by Jilin University (Changchun, 
China) and were cultured in DMEM (SH30023.01B, Hylone, 
Carlsbad, CA, USA) in an atmosphere consisting of 5% CO
2 
at 37°C. The stem-cell features of ADMSCs were identified 
by assessing the osteogenic and adipogenic differentia-
tion potential with Alizarin Red S and Oil Red O experi-
ments, respectively, as previously described (24) (Figure 
S1). Moreover, 30 minutes before injection, the surface lev-
els of CD29, CD34, CD44, CD45, and CD90 were detected 
with immunofluorescent assays (Supplementary Table 1) 
(Supplementary Figure 1). Exosomes were also collected 
from ADMSCs (Supplementary Figure 2).
Induction of ischemic injuries and AdMSC 
administration
Male adult Sprague-Dawley rats (weighing 200-300 g) 
were obtained from Changsheng Biotechnology Inc. 
(Benxi, Liaoning, China) and housed at room temperature 
(20-25°C) with a constant humidity (55 ± 5%) and access 
to food and water. All the animal experiments were con-
ducted in accordance with the Institutional Animal Ethics 
Committee and Animal Care Guidelines of Longnan Hos-
pital of Daqing and approved by the hospital’s Ethics Com-
mittee in 2016. The ischemic injuries were induced using 
MCAO: briefly, left common carotid artery was exposed 
and a small incision was made. The left middle cerebral ar-
tery was occluded with a 0.28-mm nylon filament for one 
hour and scars were closed. To verify the effect of ADMSCs, 
126 animals were randomly divided into three groups (42 
in each group) with use of random number method (mice 
with No. from 1-42, 43-84, and 85-126 were classified into 
sham, MCAO, and MCAO+ADMSC groups, respectively): 
sham group – animals were subjected to standard MCAO 
without ligation of nylon filament; MCAO group – animals 
underwent MCAO; MCAO+ADMSC group – rats received 
tail vein injection of 2.0 × 106/0.5 mL ADMSCs three times 
at 0, 12, and 24 hours after MCAO (22,23). Of the 42 rats in 
each group, 18 were used in BBB permeability assay (six 
441Li et al: ADMSCs attenuate IS by suppressing miR-21-3p
www.cmj.hr
for each recording point), six in TUNEL staining, six in TTC 
staining, six in immunofluorescent assay and ELISA assays, 
and the remaining six in reverse transcription real time 
polymerase chain reaction (RT2-PCR) and Western blotting 
assays.
BBB permeability assay
BBB permeability was measured using Evans Blue dye 
method 0, 7, and 14 days after MCAO. Briefly, 0.2 mL Ev-
ans Blue dye (2%, m/v) (314-13-6, Sigma, St Louis, MO, USA) 
was intravenously injected in the tail vein five hours before 
rats were sacrificed. The brain tissue was homogenized 
and centrifuged at 15 000 × g for 30 min. After being mixed 
with the same volume of 50% trichloroacetic acid and in-
cubated at 4°C overnight, the mixture was centrifuged at 
15 000 g for 30 min. The absorbance (OD) value at 615 nm 
was detected with a Microplate Reader (ELX-800, Biotek, 
Winooski, VT, USA) to determine the mass of Evans Blue 
dye in brain tissues per gram.
TUNeL staining and 2,3,5-TTC staining
Two weeks after model induction, the cell apoptotic rates 
in the ischemic penumbra part of brain tissues were deter-
mined with In Situ Cell Death Detection Kit (11684817910, 
Roche, Switzerland) according to the manufacturer’s in-
struction. The infarction area in the whole brain was de-
termined with 2,3,5-triphenyltetrazolium chloride (TTC) 
staining. Briefly, tissue slides were incubated with 1% TTC 
for 10 min at 37°C: pale tissue was presumed to be infarct-
ed. The percentage of infarcted area equal to infarcted 
area (mm2) / total area (mm2) × 100% was measured using 
the Image-Pro Plus software (Media Cybernetics, Bethes-
da, MD, USA).
Immunofluorescent assay
Two weeks after model induction, ischemic penumbra 
parts of brain tissues were first fixed with 4% paraformal-
dehyde for 15 min and then incubated with 0.1% Triton 
X-100 for 30 min. Afterwards, the slides were blocked in 
10% goat serum and incubated with primary antibodies 
against different indicators (Table S1) overnight at 4°C. Af-
terwards, the cells were incubated with Cy3-labeled sec-
ondary antibody (Table S1) for one hour in the dark, and 
then stained with 4,6-diamino-2-phenyl indole (DAPI) for 
5 min at room temperature. Results were detected with 
fluorescent microscopy (BX53, OLYMPUS, Tokyo, Japan) at 
400 × magnification.
enzyme-linked immunosorbent assay (eLISA)
Two weeks after model induction, the production of IL-6 
(H007), IL-1β (H002), and TNF-α (H052) (Nanjingjiancheng 
Bioengineering Institute, Nanjing, Jiangsu, China) was 
measured using ELISA kits according to the manufacturer’s 
instructions.
Reverse transcription real time polymerase chain 
reaction
Two weeks after model induction, total RNA in brain tissues 
was extracted with RNA Purified Total RNA Extraction Kit 
(RP1201, BioTeke, Beijing, China) and reversely transcribed 
into cDNA with use of Super M-MLV reverse transcriptase 
(RP6502, BioTeke). The reaction mixture of RT2-PCR system 
contained 10 μL of 2 × Power Taq PCR MasterMix (PR1702, 
BioTeke), 0.5 μL of each primer (miR-21-3p, forward: 5’- 
ACACTCCAGCTGGGCAACACCAGTCGATGGGC-3’, reverse: 
5’- CTCAACTGGTGTCGTGGA-3’; U6, forward: 5’- CTCGCT-
TCGGCAGCACA-3’; reverse, 5’- AACGCTTCACGAATTT-
GCGT-3’), 1 μL of the cDNA template, and 8 μL of RNase-
free H2O. Amplification was performed routinely with 
ExicyclerTM 96 (BIONEER, Daejeon, Republic Korea), and 
the relative expression level of miR-21-3p was calculated 
according to the formula 2-∆∆ct.
Western blotting assay
Two weeks after model induction, total protein prod-
uct was extracted with the Total Protein Extraction Kit 
(WLA019, Wanleibio, Shenyang, China). Then 40 μg of pro-
tein was subject to a 10% sodium dodecylsulfate poly-
acrylamide gel electrophoresis before membrane transfer. 
Primary antibodies against target proteins (Table S1) were 
incubated with membranes at 4°C overnight, and second-
ary HRP IgG antibodies (1:5000) were incubated with the 
membranes for 45 min at 37°C. The blots were developed 
using Beyo ECL Plus reagent (E002-5, 7seaBiotech, Shang-
hai, China). The results were detected in the Gel Imaging 
System and analyzed with Gel-Pro-Analyzer (Media Cyber-
netics, Rockville, MD, USA).
dual luciferase assay
The direct interaction between miR-21-3p and MAT2B 
was detected with dual luciferase assay by Dual Lu-
ciferase Assay kit according to the manufacturer’s in-
struction. Wild and mutant sequences of MAT2B 3’UTR 
were synthesized by Sangon Biotech (Shanghai, 
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FIGURe 1. Administration of adipose-derived mesenchymal stem cells (AdMSCs) improved blood-brain barrier (BBB) condition 
in brain tissues of rats with middle cerebral artery occlusion (MCAo). (A) Quantitative analysis of evans blue dye detection of BBB 
condition. (B) Representative images of immunofluorescence detection of oX-42. (C) Representative images of immunofluorescence 
detection of Zo-1. (D) Representative images of immunofluorescence detection of Zo-1. Asterisk indicates P < 0.05 vs sham group. 
dagger indicates P < 0.05 vs MCAo group. each assay was replicated six times. dAPI – 4,6-diamino-2-phenyl indole.
FIGURe 2. Administration of adipose-derived mesenchymal stem cells (AdMSCs) attenuated inflammation response in brain tissues 
of rats with middle cerebral artery occlusion (MCAo). (A) Quantitative analysis of IL-1β. (B) Quantitative analysis of IL-6. (C) Quantita-
tive analysis of TNF-α. Asterisk indicates P < 0.05 vs sham group. dagger indicates P < 0.05 vs MCAo group. each assay was replicated 
six times.
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China) and ligated to psiCHECK-2 plasmid. For luciferase 
reporter assay, rat normal neuron cells (0.5 × 104 cells per 
well) (1-5065, Chi Scientific, Shanghai, China) were plated 
in a 96-well plate 24 hours before transfection with use 
of Lipofectamine 2000 according to the manufacturer’s 
instruction. Renilla luciferase plasmid (psi-CHECK2) was 
used as the internal control for the determination of 
transfection efficiency. Forty-eight hours after the trans-
fection of different combinations of vectors and mimics 
(miR-21-3p mimics and negative control mimics, Thermo 
Scientific Dharmacon, Shanghai, China), fluorescence in-
tensity was detected with a Microplate Reader (GloMax, 
Promega, Madison, WI, USA).
hypoxia/re-oxygenation model of in vitro and miR-21-
3p inhibition
Human nerve cell line SH-SY5Y (CRL-2266, ATCC) was cul-
tured in F12 + DMEM supplemented with 10% FBS in a 
humidified atmosphere of 5% CO2 at 37°C. H/R adminis-
tration of SH-SY5Y cells was performed by incubating the 
cells in hypoxic conditions (1% O2 and 5% CO2) at 37°C for 
FIGURe 3. Administration of adipose-derived mesenchymal stem cells (AdMSCs) suppressed apoptosis and infarction in brain tissue 
of rats with middle cerebral artery occlusion (MCAo). (A) Quantitative analysis and representative images of TUNeL staining detec-
tion of apoptosis. (B) Quantitative analysis and representative images of Western blotting assays detection of Bax, Bcl-2, and cleaved 
caspase-3. (C) Quantitative analysis and representative images of 2,3,5-triphenyltetrazolium chloride staining. Asterisk indicates 
P < 0.05 vs sham group. dagger indicates P < 0.05 vs MCAo group. each assay was replicated six times.
RESEARCH ARTICLE444 Croat Med J. 2019;60:439-48
www.cmj.hr
six hours followed by 24 hours of reoxygenation. To assess 
the role of miR-21-3p in the ischemic neuronal injuries, 
miR-21-3p and negative control inhibitor (Thermo Scien-
tific Dharmacon) were transfected into SH-SY5Y cells with 
Lipofectamine 2000 according to the manufacturer’s in-
struction. Moreover, the cells were incubated with ADM-
SC-derived exosomes (2 × 108 particles) for 24 hours, and 
the effect on miR-21-3p expression was detected with 
RT2-PCR.
Flow cytometry
The effect of miR-143-3p on cell apoptosis was assessed 
using an Annexin V-FITC Apoptosis Detection Kit (JingMei 
Biotech, Beijing, China) according to the manufacturer’s in-
structions, and the apoptotic rates were analyzed using a 
FACScan flow cytometry (Accuri C6, BD Biosciences, San 
Jose, CA, USA).
Statistical analysis
Normality testing was performed with Kolmogorov-
Smirnov test. The data are expressed as mean ± standard 
deviation (SD). The overall effect of ADMSCs was analyzed 
with the Kruskal-Wallis test and Wilcoxon signed rank sum 
test. The P values were adjusted using Bonferroni method. 
The significance level was 0.05 (two tailed P value). The 




ADMSCs were isolated from adipose tissues surrounding 
the epididymis of rats. ADMSCs were positive for CD29, 
CD40, and CD90 and negative for CD34 and CD45 (Supple-
mentary Figure 1A), which indicates typical surface antigen 
characteristics of ADMSCs. Compared with adipose cells, 
deposition of Alizarin Red (Supplementary Figure 1B) and 
Oil Red (Supplementary Figure 1C) was detected in ADM-
FIGURe 4. Administration of adipose-derived mesenchymal stem cells (AdMSCs) induced miR-21-3p expression and suppressed 
MAT2B expression in brain tissues of rats with middle cerebral artery occlusion (MCAo). (A) Representative analysis of reverse tran-
scription real time polymerase chain reaction detection of miR-21-3p level. (B) Representative analysis and Western blotting detec-
tion of MAT2B level. Asterisk indicates P < 0.05 vs sham group. dagger indicates P < 0.05 vs MCAo group. each assay was replicated 
six times.
FIGURe 5. dual luciferase assay detection of the interaction 
between miR-21-3p and MAT2B in normal rat neuron cells. 
each assay was replicated three times. NC – negative control; 
WT – wild type; MUT – mutant type.
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SCs, showing the cells’ osteogenic and adipogenic differ-
entiation potential, respectively. Taken together, these re-
sults confirmed the successful generation of ADMSCs.
AdMSCs administration improved BBB condition and 
suppressed apoptosis, infarction, and inflammation in 
brain tissues of MCAo rats
Increased Evans Blue dye amount in rat brains indicated 
that ischemic injuries increased the BBB permeability. Al-
though the BBB condition could be restored even without 
any treatment, the ADMSCs administration accelerated 
the recovery (Figure 1A). Moreover, immunofluorescent 
assay showed that ADMSCs administration decreased OX-
42 production and distribution, and increased the distri-
bution of ZO-1 and Claudin-5 (Figure 1B-1D), confirming 
the beneficial effect of ADMSCs on BBB condition. ADM-
SCs administration also suppressed apoptosis and inflam-
mation and significantly inhibited the production of IL-1β, 
IL-6, and TNF-α when compared with the MCAO group 
(Figure 2A-2C) (P = 0.001). TUNEL assays showed that ADM-
SC administration decreased the proportion of apoptotic 
FIGURe 6. Inhibition of miR-21-3p ameliorated hypoxia/reoxygenation-induced damage in Sh-SY5Y cells. (A) Quantitative analysis 
of reverse transcription real time polymerase chain reaction detection of miR-21-3p. (B) Quantitative analysis and representa-
tive images of flow cytometry detection of apoptosis. (C) Quantitative analysis results of IL-1β. (D) Quantitative analysis of IL-6. (E) 
Quantitative analysis of TNF-α. (F) Quantitative analysis and a representative image of Western blotting detection of MAT2B. Asterisk 
indicates P < 0.05 vs control group. dagger indicates P < 0.05 vs h/R+Inhibitor group. each assay was replicated six times. NC – nega-
tive control. h/R – hypoxia/re-oxygenation.
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cells (stained brown) (29.3 ± 6.1%) compared with MCAO 
group (43.8 ± 10.9%) (P = 0.0001) (Figure 3). At the molecu-
lar level, ADMSCs suppressed the expression levels of Bax 
and cleaved caspase-3, while they increased Bcl-2 level 
(Figure 3; Supplementary Figure 3). Moreover, TTC stain-
ing showed that the ADMSC treatment also significantly 
reduced the average infarction area (Figure 3C). All these 
results confirmed the protective effect of ADMSCs against 
ischemic injuries.
Protective effect of AdMSCs on brain tissues was 
associated with the change in miR-21-3p-mediated 
MAT2B expression
To provide more information on the treatment mechanism 
associated with ADMSCs, we detected the levels of miR-21
-3p and its downstream effector MAT2B in rat brain tissues. 
The miR-21-3p level was first increased by MCAO surgery 
and then decreased by ADMSC administration (Figure 4A). 
In response to the changes in miR-21-3p level, MAT2B ex-
pression was down-regulated and then up-regulated (Fig-
ure 4B; Supplementary Figure 3). To verify the direct inter-
action between miR-21-3p and MAT2B, we also performed 
dual luciferase assay with normal rat neuron cells. Co-
transfection with miR-21-3p mimics and MAT2B promot-
er sequence suppressed luciferase activity. However, co-
transfection with miR-21-3p mimics and MAT2B promoter 
mutant type did not influence luciferase activity (Figure 5), 
confirming the specific regulation effect of miR-21-3p on 
MAT2B in neural cells.
Inhibition of miR-21-3p suppressed apoptosis and 
inflammation by inducing MAT2B expression in h/R Sh-
SY5Y cells
The ability of ADMSCs to protect H/R-injured neural 
cells by inhibiting miR-21-3p level was further verified 
by suppressing miR-21-3p level in human nerve cell line 
SH-SY5Y (Figure 6A). The increased apoptosis rate and 
production of IL-1β, IL-6, and TNF-α induced by H/R ad-
ministration were all suppressed by miR-21-3p inhibition 
(Figure 6B-6E). The effect was associated with the up-
regulation of MAT2B (Figure 6F; Supplementary Figure 
3). Moreover, the incubation of H/R SH-SY5Y cells with 
ADMSC-derived exosomes also decreased the miR-21-
3p level (Supplementary Figure 4), which supported the 
conclusions from the in vivo assays and confirmed that 
the inhibition of miR-21-3p by ADMSCs could serve as 
a promising strategy to protect brain tissues against 
ischemic injuries.
dISCUSSIoN
Our results showed that the treatment effect of ADMSCs 
on brain tissues affected by IS was associated with miR-
21-3p suppression, which contributed to the MAT2B up-
regulation.
MiRs are a class of small non-coding RNA members, 18 to 
25 nucleotides long (8). By binding directly to the 3’-un-
translated region of the targets, they regulate the level of 
mRNAs. miRs are also key regulators of neurodegenera-
tive and neuropsychiatric disorders and tumors (25,26) 
and are involved in signaling transduction alterations-as-
sociated ischemic injuries, with either protective or detri-
mental effect. For example, Barteneva et al (27) reported 
that exosome-mediated miR-124 transfer promoted neu-
rogenesis after ischemia. Contrary to this, Jiang et al (11) 
indicated that repeated remote ischemic postcondition-
ing attenuated left ventricular remodeling via remote miR-
29a transfer. In the current study, the protective effect of 
ADMSCs was explored by focusing on miR-21-3p function. 
The miR was proved to be abnormally up-regulated dur-
ing IS (11,14). Moreover, Ge et al (14) attributed the impair-
ments induced by miR-21-3p up-regulation to its suppres-
sive effect on MAT2B. This conclusion was confirmed in our 
study: ADMSCs administration suppressed the miR-21-3p 
level in vivo, which up-regulated the MAT2B expression. 
Moreover, the dual luciferase assay with rat normal neu-
ron cells confirmed the direct binding of miR-21-3p to the 
promoter of MAT2B in the nervous system, which support-
ed the regulation sequence from miR-21-3p to MAT2B by 
ADMSCs. The current study also verified the possible treat-
ment potential of miR-21-3p inhibition in ischemic injuries 
with human SH-SY5Y cells: the inhibition of miR-21-3p by 
inhibitor of ADMSC-derived exosomes suppressed apop-
tosis and inflammation in H/R-treated cells, which was also 
associated with MAT2B up-regulation.
Methionine adenosyltransferase (MAT) is an enzyme in-
volved in cell cycle regulation (28). Mammals have three 
major MAT genes: MAT1A, MAT2A, and MAT2B. MAT2B en-
codes a regulatory β subunit, which modulates the activity 
of MAT2A-encoded isoenzyme (MATII) (29). The function of 
MAT2B is generally related to oncogenesis. For example, in 
hepatoma cells, TNF-induced activation of MAT2B further 
promoted tumor growth via NF-κB pathway (30). This in-
teraction between MAT2B and NF-κB pathway also forms 
the basis of the miR-21-3p/MAT2B function in regulating 
inflammation (14). Thus, the effect of ADMSCs on miR-21-
3p/MAT2B explained the mechanism behind anti-apopto-
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sis and anti-inflammation effect of the cells. Moreover, the 
current study showed that the effect of ADMSC on miR-21
-3p level was mediated indirectly via factors such as exo-
somes, and the inhibition factors transferred by exosomes 
need to be further explored.
This study confirmed the protective effect of ADMSCs on 
brain tissue against ischemic injuriy. Additionally, it also 
demonstrated that the effect was exerted by suppressing 
miR-21-3p expression, which then up-regulated MAT2B 
and subsequently inhibited apoptosis and inflammation in 
brain tissue. However, the current study is a preliminary ex-
planation of the mechanism driving the anti-IS function of 
ADMSCs limited by the study approach, which failed to as-
sess the direct effect of ADMSCs on neural cells. Moreover, 
we did not assess the long-term effect of ADMSCs on IS in-
juries. Future studies are warranted to further elucidate the 
mechanisms underlying the ADMSCs function.
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